WASHINGTON, DC—Patients with angina but no obstructive coronary artery disease (ANOCA) see no reduction in coronary vasomotor dysfunction when taking the calcium channel blocker diltiazem, data from ...
C. Michael Gibson, Tijn Jansen, and Suzette Elias-Smale discuss the EDIT-CMD trial presented at ACC 2022.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results